Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Superoxide Dismutase (SOD) is an antioxidant enzyme that catalyzes the dismutation of superoxide radicals into oxygen and hydrogen peroxide, thereby protecting cells from oxidative stress. The rationale for its use in radiation sickness comes from the fact that ionizing radiation generates large amounts of reactive oxygen species (ROS), including superoxide radicals, which cause cellular and tissue damage. Animal studies have shown that exogenous administration of SOD or SOD mimetics can reduce radiation-induced injury in various tissues, such as the intestine and bone marrow, by mitigating oxidative damage. For instance, several preclinical studies (e.g., Epperly et al., Radiat. Res. 2001; M40403 studies) have demonstrated improved survival and decreased tissue damage in rodents treated with SOD or SOD mimetics after exposure to lethal or sublethal doses of radiation.

However, clinical evidence in humans is very limited. There are a few small-scale or early-phase clinical trials investigating SOD mimetics in radiation therapy contexts (mainly for protection against side effects rather than acute radiation syndrome), but robust, large-scale studies directly supporting SOD for treating or preventing classic radiation sickness are lacking. Thus, while the mechanistic rationale and animal data are strong, the translation to human clinical practice is not yet well established.

In summary, the use of SOD for radiation sickness is scientifically motivated and supported by preclinical research, but direct clinical evidence remains modest, justifying a rating of 2 out of 5 for evidence.

More about Superoxide Dismutase
More about Radiation Sickness

Other ingredients used for Radiation Sickness

Other health conditions supported by Superoxide Dismutase

Products containing Superoxide Dismutase